Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| VYNE Therapeutics Inc. | 119,667 | reported | 09 Mar 2020 | tx 12+546,910 |
| Silexion Therapeutics Corp | 65,471 | reported | 20 Feb 2026 | tx 1+64,350 |
| Foamix Pharmaceuticals Ltd. | 0 | reported | 09 Mar 2020 | tx 24+325,757−972,630 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Feb 2026 | GRANT_AWARD | Silexion Therapeutics Corp | 64,350 | 0.00 USD | |
| 09 Mar 2020 | OTHER | Foamix Pharmaceuticals Ltd. | 116,501 | — | |
| 09 Mar 2020 | OTHER | Foamix Pharmaceuticals Ltd. | 14,077 | — | |
| 09 Mar 2020 | OTHER | Foamix Pharmaceuticals Ltd. | 94,996 | — | deriv |
| 09 Mar 2020 | OTHER | Foamix Pharmaceuticals Ltd. | 96,365 | — | deriv |
| 09 Mar 2020 | OTHER | Foamix Pharmaceuticals Ltd. | 35,093 | — | deriv |
| 09 Mar 2020 | OTHER | Foamix Pharmaceuticals Ltd. | 196,205 | — | deriv |
| 09 Mar 2020 | OTHER | Foamix Pharmaceuticals Ltd. | 60,389 | — | deriv |
| 09 Mar 2020 | OTHER | Foamix Pharmaceuticals Ltd. | 60,000 | — | deriv |
| 09 Mar 2020 | OTHER | Foamix Pharmaceuticals Ltd. | 202,004 | — | deriv |
| 09 Mar 2020 | OTHER | Foamix Pharmaceuticals Ltd. | 18,000 | — | deriv |
| 09 Mar 2020 | OTHER | Foamix Pharmaceuticals Ltd. | 24,125 | — | deriv |
| 09 Mar 2020 | OTHER | Foamix Pharmaceuticals Ltd. | 5,469 | — | deriv |
| 09 Mar 2020 | GRANT_AWARD | VYNE Therapeutics Inc. | 8,339 | — | |
| 09 Mar 2020 | GRANT_AWARD | VYNE Therapeutics Inc. | 69,012 | — | |
| 09 Mar 2020 | GRANT_AWARD | VYNE Therapeutics Inc. | 57,086 | — | deriv |
| 09 Mar 2020 | GRANT_AWARD | VYNE Therapeutics Inc. | 35,544 | — | deriv |
| 09 Mar 2020 | GRANT_AWARD | VYNE Therapeutics Inc. | 119,667 | — | deriv |
| 09 Mar 2020 | GRANT_AWARD | VYNE Therapeutics Inc. | 10,663 | — | deriv |
| 09 Mar 2020 | GRANT_AWARD | VYNE Therapeutics Inc. | 14,291 | — | deriv |
| 09 Mar 2020 | GRANT_AWARD | VYNE Therapeutics Inc. | 3,239 | — | deriv |
| 09 Mar 2020 | GRANT_AWARD | VYNE Therapeutics Inc. | 56,275 | — | deriv |
| 09 Mar 2020 | GRANT_AWARD | VYNE Therapeutics Inc. | 20,789 | — | deriv |
| 09 Mar 2020 | GRANT_AWARD | VYNE Therapeutics Inc. | 116,231 | — | deriv |
| 09 Mar 2020 | GRANT_AWARD | VYNE Therapeutics Inc. | 35,774 | — | deriv |